Coronavirus disease 2019 and pregnancy
Main Article Content
Keywords
Respiratory Tract Infections, Pregnancy, Coronavirus Infections
Abstract
Historically, viral respiratory infections in pregnant women have shown an increase in the risk of morbidity and mortality. With regards to COVID-19, information is limited and a greater risk of severe morbidity or mortality has not been shown, when compared to general population; however, pregnant women with comorbidities such as obesity, type 2 diabetes mellitus and hypertension have shown a greater severity of the disease, consistent with the general population with these comorbidities. The risk of vertical transmission appears to be low: it has not been demonstrated in any case during the current outbreak of COVID-19 in China, nor in previous epidemics of similar coronaviruses (SARS-CoV and MERS-CoV). Existing studies have not demonstrated the presence of the virus in genital fluid, amniotic fluid or maternal milk. Described cases of infection in newborns probably come from horizontal transmission, which suggests breastfeeding with respiratory hygiene measures. Given that COVID-19 is a new disease that has extended around the world and that current knowledge is still insufficient, it is mandatory the continued accumulation of data to discover in depth the action mechanisms of SARS-CoV-2 virus, responsible for the disease, and constant update of means of prevention and handling of the disease.
References
1. World Health Organization. WHO Coronavirus disease (COVID-19) Dashboard. [Consultado el 6 de julio de 2020]. Disponible en https://covid19.who.int/
2. Secretaría de Salud. Información general COVID-19 México. México:Secretaría de Salud [Internet];2020 [consultado el 6 de julio de 2020]. Disponible en https://coronavirus.gob.mx/datos/
3. Inzunza-Cervantes G, Ornelas-Aguirre JM, Trujillo-García JJ, Peña-Valenzuela AN. Para entender el SARS-CoV-2:un análisis de la pandemia actual. Rev Med Inst Mex Seguro Soc. COVID-19. 2020:1-10. Disponible en http://revistamedica.imss.gob.mx/editorial/index.php/revista_medica/article/view/3673/3737
4. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China:summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020. doi:10.1001/jama.2020.2648
5. Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. N Engl J Med. 2014;370(23):2211-8. doi:10.1056/NEJMra1213566
6. Siston AM, Rasmussen SA, Honein AM, Fry AM, Seib K, Callaghan WM, et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA. 2010;303(15):1517-25. doi:10.1001/jama.2010.479
7. Harris JW. Influenza occurring in pregnant women. JAMA. 1919;72(14):978-80. doi:10.1001/jama.1919.02610140008002
8. Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004;191(1):292-7. doi:10.1016/j.ajog.2003.11.019
9. Torres-Ramírez A. La influenza pandémica A(H1N1) en mujeres embarazadas. Ginecol Obstet Mex. 2010;78(2):121-7.
10. Alfaraj SH, Al-Tawfiq JA, Memish ZA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy:report of two cases and review of the literature. J Microbiol Immunol Infect. 2019;52(3):501-3. doi:10.1016/j.jmii.2018.04.005
11. Yan J, Guo J, Fan C, Juan J, Yu X, Li J, et al. Coronavirus disease 2019 (COVID-19) in pregnant women:a report based on 116 cases. Am J Obstet Gynecol. 2020;S0002-9378(20)30462-2. doi:10.1016/j.ajog.2020.04.014
12. Baud D, Greub G, Favre G, Gengler C, Jaton K, Dubruc E, et al. Second-trimester miscarriage in a pregnant woman with SARS-CoV-2 infection JAMA. 2020;e207233. doi:10.1001/jama.2020.7233
13. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women:a retrospective review of medical records. Lancet. 2020;395(10226):809-15. doi:10.1016/S0140-6736(20)30360-3
14. Chen L, Li Q, Zheng D, Jiang H, Wei Y, Zou L, et al. Clinical characteristics of pregnant women with Covid-19 in Wuhan, China. N Engl J Med. 2020;NEJMc2009226. doi:10.1056/NEJMc2009226
15. Qiancheng X, Jian S, Lingling P, Lei H, Xiaogan J, Weihua L, et al. Coronavirus disease 2019 in pregnancy. Int J Infect Dis. 2020;95:376-83. doi:10.1016/j.ijid.2020.04.065
16. Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19:a systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. 2020. doi:10.1111/aogs.13867
17. Pierce-Williams RAM, Burd J, Felder L, Khoury R, Bernstein PS, Avila K, Penfield CA, et al. Clinical course of severe and critical COVID-19 in hospitalized pregnancies:a US cohort study. Am J Obstet Gynecol MFM. 2020:100134. doi:10.1016/j.ajogmf.2020.100134
18. Lira-Lucio JA, Roldán-Rodríguez E, Ochoa-Millán JG, Hernández-Escobar L, Padilla-Rivera CI, Ochoa-Gaitán G. Factores asociados con mal pronóstico en embarazadas con diagnóstico de SARS-CoV-2. Ginecol Obstet Mex. 2020;88(7):450-7. doi:10.24245/gom.v88i7.4242
19. Zeng H, Xu C, Fan J, Tang Y, Deng Q, Zhang W, et al. Antibodies in infants born to mothers with COVID-19 pneumonia. JAMA. 2020;323(18):1848-9. doi:10.1001/jama.2020.4861
20. Dong L, Tian J, He S, Zhu C, Wang J, Liu C, et al. Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn. JAMA. 2020;323(18):1846-8. doi:10.1001/jama.2020.4621
21. Kirtsman M, Diambomba Y, Poutanen SM, Malinowski AK, Vlachodimitropoulou E, Parks WT, et al. Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection. CMAJ. 2020;cmaj.200821. doi:10.1503/cmaj.200821
22. Zamaniyan M, Ebadi A, Aghajanpoor Mir S, Rahmani Z, Haghshenas M, Azizi S. Preterm delivery in pregnant woman with critical COVID-19 pneumonia and vertical transmission. Prenat Diagn. 2020. doi:10.1002/pd.5713
23. Zeng L, Xia S, Yuan W, Yan K, Xiao F, Shao J, et al. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr. 2020:e200878. doi:10.1001/jamapediatrics.2020.0878
24. Breslin N, Baptiste C, Gyamfi-Bannerman C, Miller R, Martinez R, Bernstein K, et al. COVID-19 infection among asymptomatic and symptomatic pregnant women:two weeks of confirmed presentations to an affiliated pair of New York City Hospitals. Am J Obstet Gynecol MFM. 2020;100118. doi:10.1016/j.ajogmf.2020.100118
25. Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X, et al. Clinical features and obstetric and neonatal outcomes of pregnant patients with COVID-19 in Wuhan, China:a retrospective, single-centre, descriptive study. Lancet Infect Dis. 2020;20(5):559-64. doi:10.1016/S1473-3099(20)30176-6
26. Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2:maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med2020. doi:10.5858/arpa.2020-0901-SA
27. Marinelli KA, Lawrence RM. Safe handling of containers of expressed human milk in all settings during the SARS-CoV-2 (COVID-19) pandemic. J Hum Lact. 2020:890334420919083. doi:10.1177/0890334420919083
28. World Health Organization. Breastfeeding with COVID-19 [Internet]. Geneva:WHO;2020 [consultado el 6 de julio de 2020]. Disponible en https://www.who.int/health-topics/breastfeeding#tab=tab_1
29. Hantoushzadeh S, Shamshirsaz AA, Aleyasin A, Seferovic MD, Aski SK, Arian SE, et al. Maternal death due to COVID-19 disease. Am J Obstet Gynecol. 2020:S0002-9378(20)30516-0. doi:10.1016/j.ajog.2020.04.030
30. Ramos Amorim MM, Soligo-Takemoto ML, Borges da Fonseca E. Maternal deaths with coronavirus disease 2019:a different outcome from low- to middle-resource countries?. Am J Obstet Gynecol. 2020;S0002-9378(20)30471-3. doi:10.1016/j.ajog.2020.04.023
31. Secretaría de Salud. Informe semanal de notificación inmediata de muerte materna. Semana epidemiológica 27 de2020. México:Secretaría de Salud, Dirección General de Epidemiología [Internet];2020 [consultado el 6 de julio de 2020]. Disponible en https://www.gob.mx/cms/uploads/attachment/file/561674/MM_2020_SE27.pdf
32. Lumbreras-Marquez MI, Campos-Zamora M, Lizaola-Diaz de Leon H, Farber MK. Maternal mortality from COVID-19 in Mexico. Int J Gynaecol Obstet. 2020;150(2):266-7 doi:10.1002/ijgo.13250
33. Sánchez-Carrillo V, Ávila-Vergara MA, Peraza-Garay F, Vadillo-Ortega F, Palacios-González B, García-Benavente D. Complicaciones perinatales asociadas con la ganancia excesiva de peso durante el embarazo. Ginecol Obstet Mex. 2017;85(2):64-70.
34. Sutton D, Fuchs K, D'Alton M, Goffman D. Universal screening for SARS-CoV-2 in women admitted for delivery. N Engl J Med. 2020:NEJMc2009316. doi:10.1056/NEJMc2009316
35. Secretaria de Salud. Lineamiento para la prevención y mitigación de COVID-19 en la atención de embarazo, parto, puerperio y de la persona recién nacida. México:Secretaría de Salud [Internet];2020 [consultado el 23 de mayo de 2020]. Disponible en https://funsalud.org.mx/lineamiento-para-la-prevencion-y-mitigacion-de-covid-19-en-la-atencion-del-embarazo-parto-puerperio-y-de-la-persona-recien-nacida/
Article Sidebar
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors retain their copyright and grant the Revista Médica del IMSS the right of first publication. Articles are distributed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which allows sharing as long as the author and the original source are properly credited.